New antiepileptic drugs, cost-efficacy analysis
Objective: to optimize pharmacotherapy in patients with epilepsy and to evaluate the clinical and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine, topiramate, and oxcarbazepine.Patients and methods. The study enrolled 134 patients (women, 69.03%;...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
IMA-PRESS LLC
2014-01-01
|
| Seri Bilgileri: | Неврология, нейропсихиатрия, психосоматика |
| Konular: | |
| Online Erişim: | https://nnp.ima-press.net/nnp/article/view/226 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|